Search

ICADE.

Cerrado

SectorSalud

21.9 0.46

Resumen

Variación precio

24h

Actual

Mínimo

21.84

Máximo

21.94

Métricas clave

By Trading Economics

Ingresos

-92M

Ventas

-126M

624M

Rentabilidad por dividendo

20.1

Margen de beneficio

-14.707

Empleados

969

EBITDA

-95M

138M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 meses

-4.55% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

20.10%

2.26%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

9.6M

1.6B

Apertura anterior

21.44

Cierre anterior

21.9

Noticias sobre sentimiento de mercado

By Acuity

47%

53%

136 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

ICADE. Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

31 dic 2025, 22:20 UTC

Principales Movimientos del Mercado

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dic 2025, 17:31 UTC

Principales Movimientos del Mercado

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dic 2025, 16:30 UTC

Principales Movimientos del Mercado

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dic 2025, 15:19 UTC

Principales Movimientos del Mercado

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dic 2025, 15:17 UTC

Principales Movimientos del Mercado

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dic 2025, 14:37 UTC

Principales Movimientos del Mercado

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 ene 2026, 23:35 UTC

Charlas de Mercado

Gold Rises Amid Geopolitical Risks -- Market Talk

1 ene 2026, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 ene 2026, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Sold Stake in JV to Tata Steel

1 ene 2026, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 ene 2026, 09:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

31 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

31 dic 2025, 21:13 UTC

Adquisiciones, fusiones, absorciones

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dic 2025, 20:40 UTC

Charlas de Mercado

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dic 2025, 19:50 UTC

Charlas de Mercado

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dic 2025, 19:31 UTC

Charlas de Mercado

Precious Metals Cap Off Record Runs -- Market Talk

31 dic 2025, 18:50 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

31 dic 2025, 18:50 UTC

Charlas de Mercado

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dic 2025, 17:17 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dic 2025, 17:16 UTC

Principales Movimientos del Mercado

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dic 2025, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

31 dic 2025, 17:00 UTC

Adquisiciones, fusiones, absorciones

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dic 2025, 15:57 UTC

Adquisiciones, fusiones, absorciones

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dic 2025, 15:54 UTC

Charlas de Mercado

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dic 2025, 15:02 UTC

Principales Movimientos del Mercado

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dic 2025, 14:40 UTC

Adquisiciones, fusiones, absorciones

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dic 2025, 14:20 UTC

Charlas de Mercado

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dic 2025, 13:46 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

ICADE. Esperado

Precio Objetivo

By TipRanks

-4.55% caída

Estimación a 12 meses

Media 21 EUR  -4.55%

Máximo 24 EUR

Mínimo 18 EUR

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ICADE. Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

3 ratings

0

Comprar

2

Mantener

1

Vender

Puntuación técnica

By Trading Central

21.04 / 21.4Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

136 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.
help-icon Live chat